Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.080 |
None |
1.000 |
8 |
1
|
2009 |
2019 |
Hypopigmentation disorder
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
126
|
15
|
0.160 |
None |
1.000 |
6 |
2
|
1998 |
2019 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.060 |
None |
1.000 |
6 |
|
2011 |
2019 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.060 |
None |
1.000 |
6 |
1
|
2007 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.060 |
None |
1.000 |
6 |
|
2005 |
2019 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.060 |
None |
1.000 |
6 |
|
2011 |
2019 |
MiT family translocation renal cell carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
33
|
|
0.040 |
None |
1.000 |
4 |
|
2014 |
2019 |
Addictive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
332
|
56
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2019 |
WAARDENBURG SYNDROME, TYPE 4A
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases
|
Disease or Syndrome
|
12
|
11
|
0.310 |
None |
1.000 |
2 |
|
2019 |
2019 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2019 |
Albinism, Ocular
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
37
|
10
|
0.120 |
None |
1.000 |
2 |
1
|
2009 |
2019 |
Renal glomerular disease
|
group |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
221
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Von Hippel-Lindau Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
174
|
187
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Prolactinoma
|
disease |
Neoplasms; Nervous System Diseases; Endocrine System Diseases
|
Neoplastic Process
|
187
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Menstrual spotting
|
phenotype |
|
Sign or Symptom
|
27
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.110 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cardiac fibrosis
|
disease |
|
Disease or Syndrome
|
297
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Degenerative disorder
|
group |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
160
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Kidney Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
295
|
11
|
0.030 |
None |
1.000 |
3 |
1
|
2016 |
2018 |
Perivascular Epithelioid Cell Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
31
|
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |